Tarik F Massoud

Stanford University

$335,660

Attributed

$814,884

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $234.9K · FY2014–19

$250K$187.5K$125K$62.5K$0

'14

'15

'16

'17

'18

'19

Funding mix

By agency

NIH$814,884 · 2

By mechanism

R21$814,884 · 2

Top collaborators

Most similar at Stanford University

Same institution · by research overlap

Michelle Louise James$4,919,512
Christina N Curtis$16,294,717
Steven E Artandi$26,596,623
Robert C Axtell$6,769,907
Ruijiang Li$10,760,802

Others in their field

Top investigators on “Image”

Sonia M Thomas · Research Triangle Institute$700,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
Ethan Schreier · Associated Universities, Inc.$206,468,864

Research focus

ImageDetectionMolecularProteinsIn VitroCellsFutureIn VivoPhenotypeAffectMonitorMolecular ImagingStructureBiological ProcessBiological MarkersAntineoplastic AgentsBinding (Molecular Function)Cancer PreventionBindingAnti-InflammatoryCancerousCancer CellBaseBrain

Grant awards (4)

Tracking the invaders in multiple sclerosis: Highly specific TREM1-targeted PET imaging of toxic infiltrating myeloid cells and early treatment response.$234,910

R21 · FY2019 · NS

Tracking the invaders in multiple sclerosis: Highly specific TREM1-targeted PET imaging of toxic infiltrating myeloid cells and early treatment response.$195,781

R21 · FY2018 · NS

Druggable p53 misfolding in cancer: A novel in vivo molecular imaging biosensor$209,554

R21 · FY2015 · CA · contact PI

Druggable p53 misfolding in cancer: A novel in vivo molecular imaging biosensor$174,639

R21 · FY2014 · CA · contact PI